Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 392

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation

Open access
McCormick, Beryl, Winter, Kathryn, Hudis, Clifford, Kuerer, Henry Mark, Rakovitch, Eileen, Smith, Barbara L., Sneige, Nour, Moughan, Jennifer, Shah, Amit, Germain, Isabelle, Hartford, Alan C., Rashtian, Afshin, Walker, Eleanor M., Yuen, Albert, Strom, Eric A., Wilcox, Jeannette L., Vallow, Laura A., Small, William, Pu, Anthony T., Kerlin, Kevin, White, Julia·2015·Journal of Clinical Oncology

Abstract

Purpose: The Radiation Therapy Oncology Group 9804 study identified good-risk patients with ductal carcinoma in situ (DCIS), a breast cancer diagnosis found frequently in mammographically detected cancers, to test the benefit of radiotherapy (RT) after breast-conserving surgery compared with observation. Patients and Methods: This prospective randomized trial (1998 to 2006) in women with mammographically detected low- or intermediate-grade DCIS, measuring less than 2.5 cm with margins ≥ 3 mm, compared RT with observation after surgery. The study was designed for 1,790 patients but was closed early because of lower than projected accrual. Six hundred thirty-six patients from the United States and Canada were entered; tamoxifen use (62%) was optional. Ipsilateral local failure (LF) was the primary end point; LF and contralateral failure were estimated using cumulative incidence, and overall and disease-free survival were estimated using the Kaplan-Meier method. Results: Median follow-up time was 7.17 years (range, 0.01 to 11.33 years). Two LFs occurred in the RT arm, and 19 occurred in the observation arm. At 7 years, the LF rate was 0.9% (95% CI, 0.0% to 2.2%) in the RT arm versus 6.7% (95% CI, 3.2% to 9.6%) in the observation arm (hazard ratio, 0.11; 95% CI, 0.03 to 0.47; P < .001). Grade 1 to 2 acute toxicities occurred in 30% and 76% of patients in the observation and RT arms, respectively; grade 3 or 4 toxicities occurred in 4.0% and 4.2% of patients, respectively. Late RT toxicity was grade 1 in 30%, grade 2 in 4.6%, and grade 3 in 0.7% of patients. Conclusion: In this good-risk subset of patients with DCIS, with a median follow-up of 7 years, the LF rate was low with observation but was decreased significantly with the addition of RT. Longer follow-up is planned because the timeline for LF in this setting seems protracted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2014.57.9029

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 392

Metadata

Authors
McCormick, B., Winter, K., Hudis, C., Kuerer, H. M., Rakovitch, E., Smith, B. L., Sneige, N., Moughan, J., Shah, A., Germain, I., Hartford, A. C., Rashtian, A., Walker, E. M., Yuen, A., Strom, E. A., Wilcox, J. L., Vallow, L. A., Small, W., Pu, A. T., Kerlin, K., & White, J.
Venue
Journal of Clinical Oncology
Published
2015-03-01
Volume
33
Issue
7
Pages
709-715
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2108995265
Cited by
392
References
25
FWCI
15.51
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation. https://app.cochat.ai/papers/10.1200/jco.2014.57.9029
The paper
McCormick, B., Winter, K., Hudis, C., Kuerer, H. M., Rakovitch, E., Smith, B. L., Sneige, N., Moughan, J., Shah, A., Germain, I., Hartford, A. C., Rashtian, A., Walker, E. M., Yuen, A., Strom, E. A., Wilcox, J. L., Vallow, L. A., Small, W., Pu, A. T., . . . White, J. (2015). RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2014.57.9029

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.